Trials / Completed
CompletedNCT04433923
Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants
Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants: Randomised Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 28 Days
- Healthy volunteers
- —
Summary
prospective single center pilot randomized open label clinical trial, conducted at the Neonatal care unit of Mansoura University Children's To assess the efficacy and safety of aluminum foil use in combination with phototherapy compared with phototherapy alone for pathological unconjugated hyperbilirubinaemia in full term newborn We enrolled 234 infants in the study who fulfilled the inclusion criteria and were randomly assigned to treatment groups, either conventional phototherapy with aluminum foil or conventional phototherapy alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phototherapy with aluminum foil | |
| DEVICE | Phototherapy without aluminum foil |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2020-06-16
- Last updated
- 2020-06-16
Source: ClinicalTrials.gov record NCT04433923. Inclusion in this directory is not an endorsement.